Yubo International Biotech Limited
YBGJ
$0.053
$0.00367.29%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -289.70K | -580.80K | -527.50K | -377.30K | -517.40K |
| Total Depreciation and Amortization | 42.40K | 48.40K | 46.00K | 46.50K | 115.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.50K | -54.90K | 160.10K | -32.20K | -- |
| Change in Net Operating Assets | -617.90K | 494.80K | 129.40K | 242.60K | -156.00K |
| Cash from Operations | -932.70K | -92.60K | -192.00K | -120.40K | -558.40K |
| Capital Expenditure | -- | -- | 18.90K | -18.90K | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 36.50K | 82.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 11.10K | -11.10K | -- |
| Cash from Investing | 0.00 | 36.50K | 112.00K | -30.00K | -- |
| Total Debt Issued | 1.03M | -- | -- | -- | 745.70K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 76.80K | 25.40K | 174.40K | 98.00K | -- |
| Cash from Financing | 1.11M | 25.40K | 174.40K | 98.00K | 745.70K |
| Foreign Exchange rate Adjustments | -177.70K | 31.10K | -143.70K | 103.10K | -186.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.00K | 300.00 | -49.30K | 50.70K | 1.10K |
